摘要 |
A pharmaceutical composition, and a method using the composition, for prevention and/or treatment of fatty liver or hepatic disease, the composition comprising, as an active ingredient, a compound of the formula (1): where R<SUP>1 </SUP>is a hydrogen atom, an acyl group, or an arylalkoxycarbonyl group; and R<SUP>2 </SUP>and R<SUP>3 </SUP>are each independently a substituted or unsubstituted alkyl group, a substituted or unsubstituted alkenyl group, or a substituted or unsubstituted alkynyl group, or R<SUP>2 </SUP>and R<SUP>3 </SUP>may combine to form a cycloalkyl group.
|